Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches
Antimicrobial Agents and Chemotherapy · 18.04.2023 · 67 (4)
DOI: 10.1128/aac.01452-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 18.04.2023. Verfasst von A J Lepak und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Wisconsin-Madison, Department of Medicine, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Infective Agents, Pneumonia, Ventilator-Associated. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | U.S. Food and Drug Administration (FDA).
Abstract (Originalsprache)
Acinetobacter baumannii- Acinetobacter calcoaceticus complex (referred to herein as A. baumannii ) treatment guidelines contain numerous older antimicrobial agents with susceptibility test interpretive criteria (STIC, also known as susceptibility breakpoints) set using only epidemiological data. We utilized a combination of in vitro surveillance data, preclinical murine thigh and lung infection models, population pharmacokinetics, simulation, and pharmacokinetic/pharmacodynamic (PK/PD) target attainment analyses to evaluate A. baumannii STIC for four commonly recommended antimicrobials from different classes (amikacin, ceftazidime, ciprofloxacin, and minocycline).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Wisconsin-Madison, Department of Medicine, Madison, Wisconsin, USA.
- Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.
- JMI Laboratories, North Liberty, Iowa, USA.
- University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: M Trang, H S Sader, S M Bhavnani, B D VanScoy, P G Ambrose, D R Andes
Förderung
- HHS | U.S. Food and Drug Administration (FDA)
Zitieren
APA
Lepak, A. J., Trang, M., Hammel, J. P., Sader, H. S., Bhavnani, S. M., VanScoy, B. D., Pogue, J. M., Ambrose, P. G., Andes, D. R., & United States Committee on Antimicrobial Susceptibility Testing (2023). Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches. Antimicrobial Agents and Chemotherapy, 67(4). https://doi.org/10.1128/aac.01452-22
Vancouver
Lepak AJ, Trang M, Hammel JP, Sader HS, Bhavnani SM, VanScoy BD, et al. Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches. Antimicrobial Agents and Chemotherapy. 2023;67(4). doi:10.1128/aac.01452-22
BibTeX
@article{Lepak2023,
author = {Lepak, A J and Trang, M and Hammel, J P and Sader, H S and Bhavnani, S M and VanScoy, B D and Pogue, J M and Ambrose, P G and Andes, D R and United States Committee on Antimicrobial Susceptibility Testing, United States Committee on Antimicrobial Susceptibility Testing},
title = {Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {4},
doi = {10.1128/aac.01452-22}
}
EUVIMED